Yixintang Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 6,028.944 million compared to CNY 5,060.022 million a year ago. Operating income was CNY 505.581 million compared to CNY 408.766 million a year ago. Net income was CNY 416.355 million compared to CNY 337.236 million a year ago. Basic earnings per share from continuing operations was CNY 0.7333 compared to CNY 0.594 a year ago. Diluted earnings per share from continuing operations was CNY 0.7243 compared to CNY 0.5921 a year ago.